Literature DB >> 24247718

hSETD1A regulates Wnt target genes and controls tumor growth of colorectal cancer cells.

Tal Salz1, Guangyao Li, Frederic Kaye, Lei Zhou, Yi Qiu, Suming Huang.   

Abstract

hSETD1A is a member of the trithorax (TrxG) family of histone methyltransferases (HMT) that methylate H3K4 at promoters of active genes. Although misregulation of mixed lineage leukemia (MLL) family proteins has been associated with acute leukemia, the role of hSETD1A in cancer remains unknown. In this study, we report that hSETD1A and its associated H3K4me3 are upregulated in human colorectal cancer cells and patient samples. Depletion of hSETD1A inhibits colorectal cancer cell growth, colony formation, and tumor engraftment. Genome-wide expression profiling of colorectal cancer cells reveals that approximately 50% of Wnt/β-catenin target genes are affected by the hSETD1A knockdown. We further demonstrate that hSETD1A is recruited to promoters of those Wnt signaling target genes through its interaction with β-catenin, a master regulator of the Wnt signaling pathway. The recruitment of the hSETD1A HMT complex confers promoter-associated H3K4me3 that leads to assembly of transcription preinitiation complex and transcriptional activation. Furthermore, the expression levels of hSETD1A are positively correlated with H3K4me3 enrichment at the promoters of Wnt/β-catenin target genes and the aberrant activation of these genes in human colorectal cancer. These results provide new biologic and mechanistic insights into the cooperative role of hSETD1A and β-catenin in regulation of Wnt target genes as well as in colorectal cancer cell growth in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24247718      PMCID: PMC5484530          DOI: 10.1158/0008-5472.CAN-13-1400

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.

Authors:  Qian Li; Lei Shi; Bin Gui; Wenhua Yu; Jiamu Wang; Di Zhang; Xiao Han; Zhi Yao; Yongfeng Shang
Journal:  Cancer Res       Date:  2011-09-21       Impact factor: 12.701

Review 2.  The Wnt signaling pathway in development and disease.

Authors:  Catriona Y Logan; Roel Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

Review 3.  The many ways of Wnt in cancer.

Authors:  Paul Polakis
Journal:  Curr Opin Genet Dev       Date:  2007-02       Impact factor: 5.578

4.  High-resolution profiling of histone methylations in the human genome.

Authors:  Artem Barski; Suresh Cuddapah; Kairong Cui; Tae-Young Roh; Dustin E Schones; Zhibin Wang; Gang Wei; Iouri Chepelev; Keji Zhao
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

5.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

6.  Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition.

Authors:  Min-Zu Wu; Ya-Ping Tsai; Muh-Hwa Yang; Chi-Hung Huang; Shyue-Yih Chang; Cheng-Chi Chang; Shu-Chun Teng; Kou-Juey Wu
Journal:  Mol Cell       Date:  2011-09-02       Impact factor: 17.970

7.  H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activation.

Authors:  Shannon M Lauberth; Takahiro Nakayama; Xiaolin Wu; Andrea L Ferris; Zhanyun Tang; Stephen H Hughes; Robert G Roeder
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

Review 8.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

9.  The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes.

Authors:  Jose Sierra; Tomonori Yoshida; Claudio A Joazeiro; Katherine A Jones
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

10.  USF1 and hSET1A mediated epigenetic modifications regulate lineage differentiation and HoxB4 transcription.

Authors:  Changwang Deng; Ying Li; Shermi Liang; Kairong Cui; Tal Salz; Hui Yang; Zhanyun Tang; Patrick G Gallagher; Yi Qiu; Robert Roeder; Keji Zhao; Jörg Bungert; Suming Huang
Journal:  PLoS Genet       Date:  2013-06-06       Impact factor: 5.917

View more
  31 in total

1.  Aberrant expression of SETD1A promotes survival and migration of estrogen receptor α-positive breast cancer cells.

Authors:  Ming Li Jin; Young Woong Kim; Hong Lan Jin; Hoin Kang; Eun Kyung Lee; Michael R Stallcup; Kwang Won Jeong
Journal:  Int J Cancer       Date:  2018-10-04       Impact factor: 7.396

Review 2.  Polycomb and trithorax opposition in development and disease.

Authors:  Steven T Poynter; Cigall Kadoch
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-09-01       Impact factor: 5.814

3.  Transcriptional Changes following Cellular Knockdown of the Schizophrenia Risk Gene SETD1A Are Enriched for Common Variant Association with the Disorder.

Authors:  Darren Cameron; Derek J Blake; Nicholas J Bray; Matthew J Hill
Journal:  Mol Neuropsychiatry       Date:  2019-03-25

4.  The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion.

Authors:  Chunwan Lu; Amy V Paschall; Huidong Shi; Natasha Savage; Jennifer L Waller; Maria E Sabbatini; Nicholas H Oberlies; Cedric Pearce; Kebin Liu
Journal:  J Natl Cancer Inst       Date:  2017-01-28       Impact factor: 13.506

5.  Setd1a regulates progenitor B-cell-to-precursor B-cell development through histone H3 lysine 4 trimethylation and Ig heavy-chain rearrangement.

Authors:  Betsabeh Khoramian Tusi; Changwang Deng; Tal Salz; Leilani Zeumer; Yangqiu Li; Chi Wai Eric So; Laurence M Morel; Yi Qiu; Suming Huang
Journal:  FASEB J       Date:  2014-12-30       Impact factor: 5.191

Review 6.  A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.

Authors:  Craig L Parfett; Daniel Desaulniers
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

Review 7.  Pathogenic and Therapeutic Role of H3K4 Family of Methylases and Demethylases in Cancers.

Authors:  Aman Kumar; Niti Kumari; Nayudu Nallabelli; Rajendra Prasad
Journal:  Indian J Clin Biochem       Date:  2019-04-03

Review 8.  Critical roles of non-histone protein lysine methylation in human tumorigenesis.

Authors:  Ryuji Hamamoto; Vassiliki Saloura; Yusuke Nakamura
Journal:  Nat Rev Cancer       Date:  2015-02       Impact factor: 60.716

9.  Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators.

Authors:  Hui Yang; Tal Salz; Maria Zajac-Kaye; Daiqing Liao; Suming Huang; Yi Qiu
Journal:  FASEB J       Date:  2014-06-19       Impact factor: 5.191

Review 10.  Epigenetics of colorectal cancer: biomarker and therapeutic potential.

Authors:  Gerhard Jung; Eva Hernández-Illán; Leticia Moreira; Francesc Balaguer; Ajay Goel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-01-03       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.